ArticleFrontiers in immunology2025
Organosilicone double-long-chain diquaternary ammonium salt acts as a biofilm scavenger to ameliorate colitis induced by dextran sulfate sodium salt.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-2 combined with Lactobacillus rhamnosus GG remodels gut microbiota structure to alleviate intestinal oxidative stress injury in a mouse necrotizing enterocolitis model.Journal of translational medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The treatment of ulcerative colitis (UC) remains challenging due to limited efficacy and significant side effects. Organosilicone Double-Long-Chain Diquaternary Ammonium Salt (JUC Spray Dressing) exhibits antibacterial, anti-inflammatory, and wound-healing properties. This study aimed to evaluate the therapeutic effects of JUC Spray Dressing in a Dextran Sulfate Sodium Salt (DSS)-induced UC mouse model and explore its potential mechanisms of action. Methods: A UC model was induced in mice using 3% DSS, followed by JUC Spray Dressing enema treatment. Disease activity index (DAI), histological scores, bacterial biofilms on the intestinal mucosa, and tight junction integrity were assessed. Inflammatory cytokine levels in peripheral blood were measured, and 16S rDNA amplicon sequencing was performed to analyze cecal microbiota composition. Results: JUC Spray Dressing significantly alleviated UC symptoms and reduced colonic congestion, with no significant difference compared to other treatment groups (P > 0.05). All treatments significantly decreased the expression of inflammatory cytokines in peripheral blood (P < 0.0001), with no significant differences among the groups. Additionally, all treatments effectively reduced biofilm thickness and bacterial abundance, improving intestinal barrier integrity. JUC Spray Dressing inhibited harmful bacteria such as Conclusions: JUC Spray Dressing effectively removes intestinal bacterial biofilms, reduces inflammation, and enhances barrier function to alleviate UC symptoms. Its efficacy appeared comparable to conventional treatments, suggesting potential as an alternative therapeutic option; however, the present study did not assess mucosal safety, and dedicated toxicology studies are required to establish safety for intraluminal use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.